Anzu Special Acquisition Corp I (NASDAQ:ANZU) announced this afternoon that its stockholders voted in favor of the proposed business combination with Envoy Medical Corporation (“Envoy”), held earlier today.
Details on the vote, along with redemption numbers, have not been filed yet, but the Company expects the business combination to be consummated on September 29, 2023.
Following the Closing, the Company intends to change its name to Envoy Medical, Inc., with its Class A Common Stock and warrants expected to begin trading on the Nasdaq Stock Market under the symbols “COCH” and “COCHW”, respectively.
Anzu Special Acquisition Corp. I inked its deal with Envoy on April 18, 2023. White Bear Lake, Minnesota-based Envoy is developing an innovative cochlear implant for those suffering from hearing loss that would be fully implanted and use the ear rather than a microphone gather sound.